| (+)-pilocarpine | increases expression | EXP | | 6480464 | Pilocarpine results in increased expression of BECN1 mRNA | CTD | PMID:19138675 PMID:17971868 |
| (+)-pilocarpine | increases expression | EXP | | 6480464 | Pilocarpine results in increased expression of BECN1 mRNA | CTD | PMID:17971868 PMID:19138675 |
| (+)-pilocarpine | multiple interactions | EXP | | 6480464 | Vitamin E inhibits the reaction [Pilocarpine results in increased expression of BECN1 mRNA]; more ... | CTD | PMID:19138675 |
| (+)-pilocarpine | increases expression | EXP | | 6480464 | Pilocarpine results in increased expression of BECN1 protein | CTD | PMID:19138675 |
| (-)-citrinin | increases expression | ISO | RGD:736173 | 6480464 | Citrinin results in increased expression of BECN1 mRNA | CTD | PMID:22771370 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:736173 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BECN1 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | affects binding | ISO | RGD:733440 | 6480464 | Estradiol binds to BECN1 protein | CTD | PMID:21034808 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:736173 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BECN1 mRNA | CTD | PMID:17942748 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of BECN1 mRNA | CTD | PMID:21346803 |
| 3-methyladenine | multiple interactions | ISO | RGD:733440 | 6480464 | 3-methyladenine inhibits the reaction [BECN1 protein results in decreased susceptibility to Staurosporine] | CTD | PMID:16497721 |
| 3-methyladenine | affects response to substance | ISO | RGD:733440 | 6480464 | BECN1 protein affects the susceptibility to 3-methyladenine | CTD | PMID:22322152 |
| 3-methyladenine | multiple interactions | ISO | RGD:733440 | 6480464 | 3-methyladenine inhibits the reaction [E platinum results in increased expression of BECN1 protein] | CTD | PMID:22322152 |
| 3-methyladenine | decreases expression | EXP | | 6480464 | 3-methyladenine results in decreased expression of BECN1 mRNA; more ... | CTD | PMID:18619688 |
| 3-methyladenine | multiple interactions | ISO | RGD:733440 | 6480464 | 3-methyladenine inhibits the reaction [Hydrogen Peroxide promotes the reaction [BECN1 protein binds to PIK3C3 protein]] | CTD | PMID:20525898 |
| 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in decreased expression of BECN1 mRNA | CTD | PMID:19162173 |
| 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:736173 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of BECN1 mRNA | CTD | PMID:18648102 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:733440 | 6480464 | decitabine inhibits the reaction [sodium arsenite results in increased expression of BECN1 protein] | CTD | PMID:19577553 |
| 5-fluorouracil | multiple interactions | ISO | RGD:733440 | 6480464 | BECN1 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | CTD | PMID:16896004 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of BECN1 mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of BECN1 mRNA | CTD | PMID:21839799 |
| benzo[a]pyrene | increases expression | ISO | RGD:736173 | 6480464 | Benzo(a)pyrene results in increased expression of BECN1 mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:736173 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of BECN1 mRNA | CTD | PMID:21715664 |
| beta-lapachone | affects response to substance | ISO | RGD:733440 | 6480464 | BECN1 protein affects the susceptibility to beta-lapachone | CTD | PMID:21035436 |
| calciol | multiple interactions | ISO | RGD:733440 | 6480464 | ABT-737 inhibits the reaction [Cholecalciferol promotes the reaction [BECN1 protein binds to BCL2L1 protein]]; more ... | CTD | PMID:18628207 |
| calciol | multiple interactions | ISO | RGD:733440 | 6480464 | BECN1 mutant form inhibits the reaction [Cholecalciferol promotes the reaction [PIK3C3 protein binds to BECN1 protein]] | CTD | PMID:18628207 PMID:18628207 |
| calciol | increases expression | ISO | RGD:733440 | 6480464 | Cholecalciferol results in increased expression of BECN1 protein | CTD | PMID:18628207 |
| calcipotriol | increases expression | ISO | RGD:733440 | 6480464 | calcipotriene results in increased expression of BECN1 protein | CTD | PMID:21228817 |
| calcitriol | increases response to substance | ISO | RGD:733440 | 6480464 | BECN1 results in increased susceptibility to Calcitriol | CTD | PMID:19748465 |
| calcitriol | increases expression | ISO | RGD:733440 | 6480464 | Calcitriol results in increased expression of BECN1 mRNA | CTD | PMID:19748465 |
| calcitriol | multiple interactions | ISO | RGD:733440 | 6480464 | [CAMP results in increased activity of CEBPB] affects the reaction [Calcitriol results in increased expression of BECN1 mRNA]; more ... | CTD | PMID:19748465 |
| capsaicin | increases expression | EXP | | 6480464 | Capsaicin results in increased expression of BECN1 mRNA | CTD | PMID:20349343 |
| carmustine | decreases expression | ISO | RGD:733440 | 6480464 | Carmustine results in decreased expression of BECN1 mRNA | CTD | PMID:15980968 |
| carvedilol | increases expression | EXP | | 6480464 | carvedilol results in increased expression of BECN1 protein | CTD | PMID:20079142 |
| choline | multiple interactions | ISO | RGD:736173 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of BECN1 gene | CTD | PMID:20938992 |
| cisplatin | multiple interactions | ISO | RGD:733440 | 6480464 | BECN1 affects the reaction [NACC1 affects the susceptibility to Cisplatin] | CTD | PMID:21743489 |
| cisplatin | increases expression | ISO | RGD:736173 | 6480464 | Cisplatin results in increased expression of BECN1 mRNA | CTD | PMID:21151649 |
| cycloheximide | multiple interactions | ISO | RGD:733440 | 6480464 | Cycloheximide inhibits the reaction [arsenic trioxide results in increased expression of BECN1 protein] | CTD | PMID:16882451 |
| cyclophosphamide | multiple interactions | ISO | RGD:733440 | 6480464 | BECN1 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | CTD | PMID:16896004 |
| desferrioxamine B | multiple interactions | ISO | RGD:733440 | 6480464 | Deferoxamine inhibits the reaction [Hydrogen Peroxide affects the localization of BECN1 protein] | CTD | PMID:21742779 |
| diarsenic trioxide | multiple interactions | ISO | RGD:733440 | 6480464 | Cycloheximide inhibits the reaction [arsenic trioxide results in increased expression of BECN1 protein] | CTD | PMID:16882451 |
| diarsenic trioxide | increases expression | ISO | RGD:733440 | 6480464 | arsenic trioxide results in increased expression of BECN1 mRNA | CTD | PMID:22519831 |
| diarsenic trioxide | increases expression | ISO | RGD:733440 | 6480464 | arsenic trioxide results in increased expression of BECN1 protein | CTD | PMID:16882451 more ... |
| diarsenic trioxide | increases expression | ISO | RGD:733440 | 6480464 | arsenic trioxide results in increased expression of BECN1 protein | CTD | PMID:16882451 more ... |
| diarsenic trioxide | increases expression | ISO | RGD:733440 | 6480464 | arsenic trioxide results in increased expression of BECN1 protein | CTD | PMID:20200477 PMID:16882451 |
| diarsenic trioxide | increases expression | ISO | RGD:733440 | 6480464 | arsenic trioxide results in increased expression of BECN1 protein | CTD | PMID:16882451 PMID:20200477 |
| doxorubicin | multiple interactions | ISO | RGD:733440 | 6480464 | BECN1 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | CTD | PMID:16896004 |
| doxorubicin | multiple interactions | ISO | RGD:736173 | 6480464 | PARP1 protein promotes the reaction [Doxorubicin results in increased expression of BECN1 mRNA]; more ... | CTD | PMID:19001878 |
| doxorubicin | increases expression | ISO | RGD:736173 | 6480464 | Doxorubicin results in increased expression of BECN1 protein; more ... | CTD | PMID:19001878 |
| doxorubicin | affects response to substance | ISO | RGD:733440 | 6480464 | BECN1 protein affects the susceptibility to Doxorubicin | CTD | PMID:16718815 |
| ethanol | multiple interactions | ISO | RGD:733440 | 6480464 | wortmannin promotes the reaction [Ethanol results in increased degradation of BECN1 protein]; more ... | CTD | PMID:21410490 |
| ethanol | decreases expression | ISO | RGD:733440 | 6480464 | Ethanol results in decreased expression of BECN1 protein | CTD | PMID:21410490 |
| ethanol | increases degradation | ISO | RGD:733440 | 6480464 | Ethanol results in increased degradation of BECN1 protein | CTD | PMID:21410490 |
| fluoxetine | increases expression | ISO | RGD:733440 | 6480464 | Fluoxetine results in increased expression of BECN1 protein | CTD | PMID:20503272 |
| folic acid | multiple interactions | ISO | RGD:736173 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of BECN1 gene | CTD | PMID:20938992 |
| gamma-hexachlorocyclohexane | affects expression | EXP | | 6480464 | Lindane affects the expression of BECN1 protein | CTD | PMID:19041923 |
| gamma-hexachlorocyclohexane | multiple interactions | EXP | | 6480464 | Lindane promotes the reaction [BECN1 protein binds to BCL2 protein] | CTD | PMID:19041923 |
| hydrogen peroxide | multiple interactions | ISO | RGD:733440 | 6480464 | 3-methyladenine inhibits the reaction [Hydrogen Peroxide promotes the reaction [BECN1 protein binds to PIK3C3 protein]] | CTD | PMID:20525898 |
| hydrogen peroxide | affects localization | ISO | RGD:733440 | 6480464 | Hydrogen Peroxide affects the localization of BECN1 protein | CTD | PMID:21742779 |
| hydrogen peroxide | affects response to substance | ISO | RGD:733440 | 6480464 | BECN1 protein affects the susceptibility to Hydrogen Peroxide | CTD | PMID:21742779 |
| hydrogen peroxide | multiple interactions | ISO | RGD:733440 | 6480464 | BECN1 protein affects the reaction [Hydrogen Peroxide affects the localization of BAX protein]; more ... | CTD | PMID:21742779 |
| hydrogen peroxide | increases expression | ISO | RGD:733440 | 6480464 | Hydrogen Peroxide results in increased expression of BECN1 protein | CTD | PMID:19451193 |
| L-methionine | multiple interactions | ISO | RGD:736173 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of BECN1 gene | CTD | PMID:20938992 |
| maneb | increases expression | ISO | RGD:736173 | 6480464 | Maneb results in increased expression of BECN1 protein | CTD | PMID:22292029 |
| menadione | affects expression | ISO | RGD:733440 | 6480464 | Vitamin K 3 affects the expression of BECN1 mRNA | CTD | PMID:20044591 |
| morphine | multiple interactions | ISO | RGD:733440 | 6480464 | Morphine inhibits the reaction [BECN1 protein binds to BCL2 protein] | CTD | PMID:20190558 |
| morphine | increases expression | ISO | RGD:733440 | 6480464 | Morphine results in increased expression of BECN1 protein | CTD | PMID:20190558 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:733440 | 6480464 | Acetylcysteine inhibits the reaction [vorinostat results in increased expression of BECN1 protein] | CTD | PMID:20543569 |
| ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of BECN1 protein | CTD | PMID:22727909 |
| paclitaxel | multiple interactions | ISO | RGD:733440 | 6480464 | BECN1 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | CTD | PMID:16896004 |
| paraquat | multiple interactions | ISO | RGD:733440 | 6480464 | [Paraquat co-treated with MAP3K5 protein] results in increased expression of BECN1 protein; more ... | CTD | PMID:20929985 |
| paraquat | increases expression | ISO | RGD:736173 | 6480464 | Paraquat results in increased expression of BECN1 protein | CTD | PMID:22292029 |
| paraquat | increases expression | ISO | RGD:733440 | 6480464 | Paraquat results in increased expression of BECN1 protein | CTD | PMID:20929985 |
| resveratrol | multiple interactions | ISO | RGD:733440 | 6480464 | resveratrol promotes the reaction [TP53 protein binds to BECN1 protein] | CTD | PMID:23088850 |
| rosiglitazone | increases expression | ISO | RGD:733440 | 6480464 | rosiglitazone results in increased expression of BECN1 protein | CTD | PMID:21376716 |
| rotenone | increases expression | ISO | RGD:733440 | 6480464 | Rotenone results in increased expression of BECN1 protein | CTD | PMID:18032788 |
| rotenone | multiple interactions | ISO | RGD:733440 | 6480464 | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Rotenone results in increased expression of BECN1 protein]; more ... | CTD | PMID:18032788 |
| rotenone | affects response to substance | ISO | RGD:733440 | 6480464 | BECN1 protein affects the susceptibility to Rotenone | CTD | PMID:18032788 |
| sirolimus | multiple interactions | ISO | RGD:733440 | 6480464 | Sirolimus inhibits the reaction [Ethanol results in increased degradation of BECN1 protein] | CTD | PMID:21410490 |
| sirolimus | increases expression | ISO | RGD:736173 | 6480464 | Sirolimus results in increased expression of BECN1 protein | CTD | PMID:20358864 |
| staurosporine | multiple interactions | ISO | RGD:733440 | 6480464 | 3-methyladenine inhibits the reaction [BECN1 protein results in decreased susceptibility to Staurosporine] | CTD | PMID:16497721 |
| staurosporine | decreases response to substance | ISO | RGD:733440 | 6480464 | BECN1 protein results in decreased susceptibility to Staurosporine | CTD | PMID:16497721 |
| temozolomide | increases expression | ISO | RGD:733440 | 6480464 | temozolomide results in increased expression of BECN1 protein | CTD | PMID:19567134 |
| temozolomide | multiple interactions | ISO | RGD:733440 | 6480464 | Thalidomide promotes the reaction [temozolomide results in increased expression of BECN1 protein] | CTD | PMID:19567134 |
| thalidomide | multiple interactions | ISO | RGD:733440 | 6480464 | Thalidomide promotes the reaction [temozolomide results in increased expression of BECN1 protein] | CTD | PMID:19567134 |
| trans-resveratrol | multiple interactions | ISO | RGD:733440 | 6480464 | resveratrol promotes the reaction [TP53 protein binds to BECN1 protein] | CTD | PMID:23088850 |
| wortmannin | multiple interactions | ISO | RGD:733440 | 6480464 | wortmannin promotes the reaction [Ethanol results in increased degradation of BECN1 protein] | CTD | PMID:21410490 |